Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole for the Prevention of Systemic Fungal Infections in Children with Neutropenia
NCT00066599Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2003
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of voriconazole in fungal infection, sponsored by National Cancer Institute. Started Jun 2003; status: completed.
02
Drugs
voriconazole
03
Conditions
fungal infection
Beyond the preview
Go deeper on NCT00066599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00066599.